choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Sanofi Vaccines

Sanofi Vaccines Newsletter
  • Sanofi to acquire Dynavax 27 Dec 2025 09:04 GMT

    … by combining Dynavax’s vaccine portfolio with Sanofi’s global development expertise … . The deal further expands Sanofi’s vaccines portfolio and supports its long … Thomas Triomphe, Executive Vice President, Vaccines, Sanofi. “Its marketed adult hepatitis B …

  • Dynavax (DVAX) Rockets 38% on Sanofi $2-Billion Merger 27 Dec 2025 02:25 GMT

    … ) adult hepatitis B vaccine Heplisav-B—currently marketed … (NASDAQ:DVAX) shingles vaccine candidate (Z-1018), … as other vaccine pipeline projects. “Joining Sanofi will provide … vaccine portfolio,” said CEO Ryan Spencer. Dynavax (DVAX) Rockets 38% on Sanofi …

  • Sanofi buys Dynavax for $2.2 B to augment presence in adult immunisation sector 26 Dec 2025 13:29 GMT

    … a differentiated shingles vaccine candidate. The acquisition augments Sanofi's presence … bringing together Dynavax's vaccines with Sanofi's global scale … additional vaccine pipeline projects. Under the terms of the merger agreement, Sanofi …

  • Sanofi-Dynavax: A Conservative Vaccine Deal With Upside Tail Risk 25 Dec 2025 19:44 GMT

    Summary Sanofi acquires Dynavax for $15.50… 2026. SNY strengthens its adult vaccine portfolio with HEPLISAV-B, a … (DVAX) is joining forces with Sanofi (SNY) this Festivus season! Revealed … on Christmas Eve, Sanofi will acquire Dynavax for $15 …

  • Sanofi pushes ahead on adult vaccines with $2.2 billion Dynavax deal 25 Dec 2025 17:19 GMT

    … around vaccines," said William Blair analyst Matt Phipps. "Sanofi is … , it added. Vaccine makers under pressure Earlier this year, Sanofi and British … also add an experimental shingles vaccine to Sanofi's existing products …

  • Dynavax Jumps Toward Deal Value as Market Prices In Sanofi’s Takeover Premium 25 Dec 2025 14:44 GMT

    … Triomphe, Executive Vice President of Vaccines at Sanofi, stated that Dynavax enhances … Sanofi’s adult immunization presence by adding differentiated vaccines that … competing vaccines requiring three doses over six months. Additionally, Sanofi gains …

  • Sanofi’s Vaccine Lineup Gets a Shot in the Arm With $2.2B Dynavax Acquisition 24 Dec 2025 21:28 GMT

    … adding differentiated vaccines that complement Sanofi’s expertise,” Thomas Triomphe, Sanofi’s executive … vice president, vaccines, said in a … in Vaxart. Dynavax is Sanofi’s second vaccines M&A deal …

  • What Sanofi Is Getting Through The Acquisition Of Dynavax 24 Dec 2025 21:12 GMT

    Summary Sanofi will acquire Dynavax for $2. … -B, a hepatitis B vaccine, and early-stage vaccine candidates. Heplisav-B … -stage asset is the shingles vaccine candidate Z-1018 which has … ;iStock via Getty Images Sanofi to acquire Dynavax Sanofi (SNY) announced the …

  • <![CDATA[JP Morgan 2026 Preview: Sanofi Looks to Bolster Future Pipeline ]]> 24 Dec 2025 17:21 GMT

    … in immunology, respiratory disease, and vaccines. For more background, read Pharm … than rushed transformation. In 2024, Sanofi delivered solid financial results, reinforcing … in Sanofi’s broader pipeline portfolio. Two of the biggest contributors, vaccines …

  • Sanofi swoops on Dynavax with $2.5bn takeover deal 24 Dec 2025 15:46 GMT

    … Sanofi, however, is thought to be Dynavax's experimental shingles vaccine … by adding differentiated vaccines that complement Sanofi's … commitment to providing vaccine protection across the … second acquisition for Sanofi in the vaccines space this year …

Satisfied with the content?

Continue to create your account.